<DOC>
	<DOCNO>NCT00658164</DOCNO>
	<brief_summary>Patients randomize lifestyle change alone lifestyle change associate iron depletion . Iron depletion achieve remove 350 cc blood every 10-15 day accord baseline hemoglobin value venesection tolerance , ferritin &lt; 30 ng/ml transferrin saturation &lt; 25 % . Weekly phlebotomy allow carrier C282Y HFE mutation . Smaller phlebotomy ( 250 cc ) allow carrier beta-thalassaemia trait . Maintenance phlebotomy ( much require ) institute keep iron store deplete ( ferritin &lt; 50 ng/ml transferrin saturation &lt; 25 % , MCV &lt; 85 fl ) . Before start treatment , patient undergo ECG , presence hyperglycemia hypertension also echocardiography ( see exclusion criterion ) . Change diabetes medication dosage start new therapy allow HbA1C value &lt; 6 % ≥ 7 % . According accepted criterion , previously untreated patient treat metformin . If possible , newly diagnose hypertension treat Ace-inhibitors .</brief_summary>
	<brief_title>Effect Iron Depletion Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone Liver Damage Patients With Nonalcoholic Fatty Liver Disease With Increased Iron Stores</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Age ≥ 18 &lt; 75 year Ferritin &gt; 250 ng/ml and/or stainable iron biopsy NAS ≥ 2 and/or NAS 1 stage≥1 liver histology Willingness maintain diet exercise full course study Written inform consent participate study specific genetic test perform Ability comply study requirement Pregnant lactate female Diagnosis history : Type 1 diabetes , diabetes result pancreatic injury , secondary form diabetes , e.g . Cushing 's syndrome acromegaly Acute metabolic complication ketoacidosis hyperosmolar state within past 6 month Alcohol consumption &gt; 20 g/day female &gt; 30 g/day male BMI ≥ 35 Kg/ m2 Other liver disease viral hepatitis , autoimmune hepatitis , Wilson disease , define ceruloplasmin normal limit liver histology consistent Wilson disease . Alpha1antitrypsin deficiency define alpha1antitrypsin level less 80 mg/dl PiZ/PiZ PiZ/PiS genotype . *Hemochromatosis , define homozygosity C282Y HFE mutation compound heterozygosity C282Y/H63D mutation Hepatic Iron Index ≥ 1.9 . Advanced liver disease ( Child B/C cirrhosis ) , portal hypertension , hepatocellular carcinoma . Congestive heart failure ( NYHA IIV ) unstable ischemic heart disease , systolic dysfunction ( ejection fraction &lt; 45 % ) Any follow ECG abnormality : II III degree Atrial Ventricular *Block , QT &gt; 500msec , repolarization defect suggestive ischemia Malignancy within last 5 year Serum creatinine level &gt; 1.5 mg/dl male , &gt; 1.4 mg/dl female TSH outside normal range Use drug know induce NAFLD : corticosteroid , methotrexate , zidovudine , amiodarone , GH , estrogens , tamoxifene , tetracycline Lipodystrophy , dysbetalipoproteinemia , inflammatory bowel disease , HIV infection Basal hemoglobin level &lt; 11 g/dl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Nonalcoholic fatty liver disease associate increase iron store</keyword>
</DOC>